What are the outcomes of androgen deprivation therapy in prostate cancer?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18560439
Cited by: 0

Abstract

Outcomes of androgen deprivation therapy in prostate cancer include improved progression-free survival and potential benefits when combined with other therapies, although optimal use strategies vary and carry risks of adverse effects.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Breast Cancer Treatment Studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
9 February 2026